Evaluating a New Gonadotoxic Risk Stratification System
NCT05052632 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-08-13
Summary
The primary objective of this study is to assess if there is an association between a newly described gonadotoxic risk stratification system and post-treatment ovarian reserve as determined by FSH and AMH.
Conditions
Sponsors & Collaborators
-
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Leslie Appiah, MD · University of Colorado, Denver
Eligibility
- Min Age
- 8 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-01
- Primary Completion
- 2025-08-05
- Completion
- 2025-08-05
More Related Trials
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
NCT01623856 ·Status: COMPLETED
-
Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy
NCT01869218 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
NCT01653613 ·Status: UNKNOWN
-
Identification of Genomic Changes in Families Having Multiple Members With Tumors
NCT02386241 ·Status: TERMINATED
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA
-
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
NCT01500499 ·Status: COMPLETED
-
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
NCT01365962 ·Status: COMPLETED
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers
NCT01139983 ·Status: COMPLETED
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
NCT01807143 ·Status: COMPLETED
-
Molecular Epidemiology of Pediatric Germ Cell Tumors
NCT05564026 ·Status: RECRUITING
-
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
NCT00436696 ·Status: COMPLETED
-
Omics of Cancer: OncoGenomics
NCT05431439 ·Status: WITHDRAWN
-
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
NCT00002695 ·Status: COMPLETED
-
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
NCT01567722 ·Status: TERMINATED
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED
-
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
NCT03553550 ·Status: TERMINATED
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
NCT00001938 ·Status: COMPLETED